Publications by authors named "Eleanor Pinto"

Claim this Profile
C
Cost-effectiveness analysis for multinational clinical trials.
Eleanor M Pinto, Andrew R Willan, Bernie J O'Brien

Stat Med· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The value of information and optimal clinical trial design.
Andrew R Willan, Eleanor M Pinto

Stat Med· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Country specific cost comparisons from multinational clinical trials using empirical Bayesian shrinkage estimation: the Canadian ASSENT-3 economic analysis.
Andrew R Willan, Eleanor M Pinto, Bernie J O'Brien, Padma Kaul, Ron Goeree

Health Econ· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Female infertility after ileal pouch-anal anastomosis for ulcerative colitis.
Paul Johnson, Carole Richard, Anat Ravid, Leia Spencer, Eleanor Pinto

Dis Colon Rectum· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective longitudinal study of early cognitive development in tuberous sclerosis - a clinic based study.
Ayla Humphrey, Jayne Williams, Eleanor Pinto, Patrick F Bolton

Eur Child Adolesc Psychiatry· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutrophil counts, monocyte counts and cardiovascular disease in the elderly.
Eleanor M Pinto, Felicia A Huppert, Kevin Morgan, Mrc Cfas, Carol Brayne

Exp Gerontol· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival in a population sample is predicted by proportions of lymphocyte subsets.
Felicia A Huppert, Eleanor M Pinto, Kevin Morgan, Carol Brayne

Mech Ageing Dev· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Derivative chromosome 9 deletions in chronic myeloid leukemia: poor prognosis is not associated with loss of ABL-BCR expression, elevated BCR-ABL levels, or karyotypic instability.
Brian J P Huntly, Anthony J Bench, Eric Delabesse, Alistair G Reid, Juan Li, Eleanor Pinto

Blood· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis